Cedazuridine

Cedazuridine

Cedazuridine (E7727) is an orally active cytidine deaminase (CDA) inhibitor (IC50 = 0.4 µM) used in cancer research. It increases plasma decitabine levels by inhibiting its metabolism and, in combination with 5-azacytidine, reduces leukemic cell expansion in an AML mouse model. Cedazuridine is used in formulations with decitabine for treating myelodysplastic syndrome (MDS). Reagent grade, for research use only.

Molecular structure of the compound BP-43639
    • Unit
    • Price
    • Qty
    • 5 MG
    • $120.00
    • 10 MG
    • $230.00
    • 25 MG
    • $450.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire